Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 7/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.46 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.44 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1582273 | 0.78 | ENPP2 (0.47) | PTGS2AKR1C3 | |
| SCHEMBL1582276 | 0.78 | ENPP2 (0.47) | PTGS2AKR1C3 | |
| SCHEMBL8993292 | 0.77 | BCAT2 (0.35) | EPHX2PTGS2 | |
| SCHEMBL8423741 | 0.74 | EPHX2 (0.48) | EPHX2PTGS2ESR2AKR1C2AKR1C1 | |
| SCHEMBL3866203 | 0.74 | ESR2 (0.66) | EPHX2PTGS2ESR2AKR1C2AKR1C1 | |
| SCHEMBL3866202 | 0.74 | ESR2 (0.66) | EPHX2PTGS2ESR2AKR1C2AKR1C1 | |
| SCHEMBL7505910 | 0.72 | EPHX2 (0.54) | EPHX2PTGS2AKR1C2AKR1C1AKR1C3 | |
| SCHEMBL7507298 | 0.72 | EPHX2 (0.54) | EPHX2PTGS2AKR1C2AKR1C1AKR1C3 | |
| SCHEMBL7847559 | 0.70 | EPHX2 (0.49) | EPHX2PTGS2ESR2 | |
| SCHEMBL444872 | 0.69 | PTGS2 (0.69) | PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0724566-A1 | 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-08-07 | — | — | EP | disclosed |
| WO-1995011883-A1 | 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-05-04 | — | — | WO | disclosed |